Prognostic factors in patients with minor troponin-I elevation but without acute myocardial infarction

Coronary Artery Disease

Volumn 17, Issue 3, 2006, Pages 249-253

  Hak Lee, Sang ^a   Bo Yoon, Seong ^a   Jung, Jae Hun ^a   Choi, Seung Hyuk ^a   Lee, Namho ^a   Cho, Goo Yeong ^a   Oh, Dong Jin ^a   Rhim, Chong Yun ^a   Lee, Kwang Hwak ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Chest pain; Creatine kinase myocardial isoform form; Mortality determinants; Troponin

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; STATISTICAL ANALYSIS; THORAX PAIN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE, MB FORM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; RISK FACTORS; SURVIVAL ANALYSIS; TROPONIN I;

EID: 33748307367     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200605000-00008     Document Type: Article

References (28)

1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969.
2. Pham MX, Whooley MA, Evans Jr GT, Liu C, Emadi H, Tong W, et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J 2004; 148:776-782.
3. Kontos MC, Shah R, Fritz LM, Anderson FP, Tatum JL, Ornato JP, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 2004; 43:958-965.
4. Khan IA, Tun A, Wattanasauwan N, Win MT, Hla TA, Hussain A, et al. Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndrome. Am J Emerg Med 1999; 17:225-229.
5. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41:2004-2009.
6. Bucciarelli-Ducci C, Rasile C, Proietti P, Mancone M, Volponi C, Vestri A, et al. Troponin I as a specific marker of myocardial injury: from theory to clinical practice in the diagnosis of acute coronary syndrome. Coron Artery Dis 2004; 15:499-504.
7. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004; 25:1187-1196.
8. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndrome are excluded. Ann Intern Med 2005; 142:786-791.
9. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guideline for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002; 144:981-986.
10. Panteghini M, Pagani F, Yeo KJ, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004; 50:327-332.
11. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, et al. Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 2004; 93:275-279.
12. Dokainish H, Pillai M, Murphy SA, DiBattiste PM, Schweiger MJ, Lotfi A, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease. J Am Coll Cardiol 2005; 45:19-24.
13. Newby LK, Kaplan AL, Granger BB, Sedor F, Califf RM, Ohman EM. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol 2000; 85:801-805.
14. Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndrome. Am J Cardiol 2003; 91:936-940.
15. Hillis GS, Taggart P, Hillis L, Zhao N, Dalsey WC, Mangione A. Biochemical and clinical predictors of long-term outcome in patients with nonspecific chest pain and nondiagnositc electrocardiograms. Am Heart J 2003; 145:88-94.
16. Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, et al. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndrome: results from 4 large clinical trials. Am Heart J 2000; 151:16-24.
17. Yee KC, Mukherjee D, Smith DE, Kline-Rogers EM, Fang J, Mehta RH, et al. Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome. Am J Cardiol 2003; 92:1442-1444.
18. Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV, et al. Frequency and clinical implication of discordant creatine kinase-MB and troponin measurement in acute coronary syndromes. J Am Coll Cardiol 2006; 47:312-318.
19. Lovis C, Mach F, Unger PF, Bouille M, Chevrolet JC. Elevation of creatine kinase in acute severe asthma is not of cardiac origin. Intensive Care Med 2001; 27:528-533.
20. Ay H, Arsava EM, Saribas O. Creatine kinase-MB elevation after stroke is not cardiac origin: comparison with troponin T level. Stroke 2002; 33:286-289.
21. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003; 89:1303-1307.
22. McErlean ES, Deluca SA, van Lente F, Peacock IV F, Rao JS, Balog CA, et al. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndrome. Am J Cardiol 2000; 85:421-426.
23. Verheggen PW, de Maat MP, Cats VM, Haverkate F, Zwinderman AH, Kluft C, et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. Eur Heart J 1999; 20:567-574.
24. Bholasingh R, Cornel JH, Kamp O, van Straalen JP, Sanders GT, Dijksman L, et al. The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department. Am J Med 2003; 115:521-528.
25. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123:2043-2049.
26. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004; 147:931-938.
27. Alho H, Sillanaukee P, Kalela A, Jaakkola O, Laine S, Nikkari ST. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein. Alcohol Alcohol 2004; 39:312-315.
28. Relos RP, Hasinoff IK, Beilman GJ. Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit Care Med 2003; 31:2598-2603.